GLYCATED HEMOGLOBIN (HbA1C) - ANVISA Registration 81327670135

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81327670135 and manufactured by LANSION BIOTECHNOLOGY CO., LTD.. The registration is held by DNEDX COMERCIO E SERVICOS PARA PRODUTOS DA SAUDE LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.